1. HBW Insight
  2. >>Wellness
  3. >>Business

Claim That Supplement Boosts Children’s Focus Could Spur FTC Attention

 
• By Eileen Francis

Creekside Natural Therapeutics might hear from the FTC after failing to show in an industry self-regulation forum that it would correct misleading claims for its Focused Mind Jr. supplement promoted as an alternative to ADHD drugs.

Attention Please_1014394012_1200.jpg

Creekside Natural Therapeutics LLC failed to support claims that its Focused Mind Jr. supplement is an alternative to ADHD drugs for children in a review by an industry self-regulation program without enforcement authority. After failing to agree to change the advertising, the firm might get the full attention of a federal enforcement agency prioritizing false claims for children's products.

In a report published 15 January, the Council of Better Business Bureaus’ National Advertising Division said Creekside Natural didn’t submit...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Wellness

Consumers More Often Choosing Private Label First

 
• By Malcolm Spicer

First Insight report from survey conducted in April with 1,267 US consumers notes that the Private Label Manufacturers Association recorded private label sales increasing by nearly 4% in 2024 to a record $271bn.

People In US Consumer Health News: Bayer North America Treasurer Takes On CFO Role, Too

 
• By Malcolm Spicer

Bayer North America CFO with firm since 2008; Cosette VP for quality, regulatory affairs; FDA labeling review official joins ProPharma; Lifecykel, UFC veterans launch Mongolian training camp; and Beverly Hills surgeons offer skin care supplement.

HHS Wants Employees (And Public?) To Report Diversity, Equity And Inclusion Discrimination

 
• By Sue Sutter

A survey asks FDA staff to disclose whether DEI policies caused discrimination or resulted in disciplinary action against career employees over the past five years, but uses a web form that the general public also can access.